Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Early pancreatic carcinogenesis - risk factors, early symptoms, and the impact of antidiabetic drugs

P. Frič, J. Škrha, A. Šedo, P. Bušek, K. Kmochová, M. Laclav, S. Solař, B. Bunganič, M. Zavoral,

. 2016 ; 28 (7) : e19-25.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc17031771

Grantová podpora
NT14254 MZ0 CEP - Centrální evidence projektů

Risk factors (long-term diabetes, obesity) and early symptoms (new-onset diabetes, loss of weight, or persistent low body mass) are the initial symptoms of pancreatic carcinogenesis. They may be influenced by antidiabetic drugs and their correct evaluation is a prerequisite for early diagnosis of pancreatic cancer (PC). We review the risk factors, early symptoms, and the impact of antidiabetic drugs on early pancreatic carcinogenesis. The main source of data was the database Medline/PubMed and abstracts of international congresses (DDW, UEGW). The risk factors and early symptoms are integral components of the familial PC surveillance and sporadic PC screening. Preventive programs should always be include multistep and multidisciplinary procedures. The correct evaluation of antidiabetic drugs and their interactions with other components of pancreatic carcinogenesis may influence the early diagnosis of PC.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17031771
003      
CZ-PrNML
005      
20191030153848.0
007      
ta
008      
171025s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1097/MEG.0000000000000646 $2 doi
035    __
$a (PubMed)27120389
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Frič, Přemysl, $u aDepartment of Medicine and Gastroenterology, Military University Hospital bLaboratory of Endocrinology and Metabolism cInstitute of Biochemistry and Experimental Oncology, General University Hospital, 1st Faculty of Medicine, Charles University, Prague, Czech Republic. $d 1929- $7 jk01031889
245    10
$a Early pancreatic carcinogenesis - risk factors, early symptoms, and the impact of antidiabetic drugs / $c P. Frič, J. Škrha, A. Šedo, P. Bušek, K. Kmochová, M. Laclav, S. Solař, B. Bunganič, M. Zavoral,
520    9_
$a Risk factors (long-term diabetes, obesity) and early symptoms (new-onset diabetes, loss of weight, or persistent low body mass) are the initial symptoms of pancreatic carcinogenesis. They may be influenced by antidiabetic drugs and their correct evaluation is a prerequisite for early diagnosis of pancreatic cancer (PC). We review the risk factors, early symptoms, and the impact of antidiabetic drugs on early pancreatic carcinogenesis. The main source of data was the database Medline/PubMed and abstracts of international congresses (DDW, UEGW). The risk factors and early symptoms are integral components of the familial PC surveillance and sporadic PC screening. Preventive programs should always be include multistep and multidisciplinary procedures. The correct evaluation of antidiabetic drugs and their interactions with other components of pancreatic carcinogenesis may influence the early diagnosis of PC.
650    _2
$a nádorová transformace buněk $x účinky léků $7 D002471
650    _2
$a komplikace diabetu $x diagnóza $x etiologie $7 D048909
650    _2
$a časná detekce nádoru $x metody $7 D055088
650    _2
$a lidé $7 D006801
650    _2
$a hypoglykemika $x škodlivé účinky $7 D007004
650    _2
$a obezita $x komplikace $7 D009765
650    _2
$a nádory slinivky břišní $x diagnóza $x etiologie $7 D010190
650    _2
$a rizikové faktory $7 D012307
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Škrha, Jan
700    1_
$a Šedo, Aleksi, $d 1967- $7 jn20000605245
700    1_
$a Bušek, Petr $7 xx0094315
700    1_
$a Kmochová, Klára $7 xx0229134
700    1_
$a Laclav, Martin
700    1_
$a Solař, Svatopluk, $d 1969- $7 nlk20050173090
700    1_
$a Bunganič, Bohuš $7 xx0200314
700    1_
$a Zavoral, Miroslav, $d 1953- $7 xx0036686
773    0_
$w MED00001618 $t European journal of gastroenterology & hepatology $x 1473-5687 $g Roč. 28, č. 7 (2016), s. e19-25
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27120389 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20191030154328 $b ABA008
999    __
$a ok $b bmc $g 1255364 $s 992798
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 28 $c 7 $d e19-25 $i 1473-5687 $m European journal of gastroenterology & hepatology $n Eur J Gastroenterol Hepatol $x MED00001618
GRA    __
$a NT14254 $p MZ0
LZP    __
$a Pubmed-20171025

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace